Document is current
Any future updates will be listed below
-
Authors
Werth, Victoria P. https://orcid.org/0000-0003-3030-5369
Murrell, Dédée F.
Joly, Pascal
Heck, Renata
Orengo, Jamie M.
Ardeleanu, Marius
Hultsch, Verena
-
Funding
Funding for this research was provided by:
Sanofi
Regeneron Pharmaceuticals
- License Information
-
More Information
Article History
Received: 2 August 2024
Accepted: 5 September 2024
First Online: 19 October 2024
Declarations
:
: Victoria P. Werth has consulted for AbbVie, Argenx, AstraZeneca, Janssen, Kyowa Hakko Kirin, Lilly, Principia Biopharma, Regeneron Pharmaceuticals Inc., and Roche-Genentech; reports grants from Argenx, Roche-Genentech, Sanofi-Regeneron Pharmaceuticals Inc., and Syntimmune; and is a co-creator of BPDAI. Dédée F. Murrell has served as an investigator and on the advisory board for Argenx, Principia Biopharma, Regeneron Pharmaceuticals Inc., and Roche, and as an investigator for AstraZeneca; and is a co-creator of BPDAI and creator of ABQOL. Pascal Joly reports consultancy for Amgen, Argenx, AstraZeneca, Innovaderm Research, Principia Biopharma, Roche, Sanofi-Regeneron Pharmaceuticals Inc., and Thermo Fisher Scientific. Renata Heck has served as an investigator for Amgen and Pfizer. Jamie M. Orengo and Marius Ardeleanu are employees of Regeneron Pharmaceuticals Inc., and may hold company stock and or/stock options. Jamie M. Orengo is an officer of Regeneron Pharmaceuticals Inc. Verena Hultsch is an employee of Sanofi and may hold stock and/or stock options in the company.
: This narrative review article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
